← Back to All Filings

NRIX CLO Sells $47K in Stock to Cover Taxes on Vested RSUs

Low SignificanceOctober 30, 2025 at 6:32:23 PM EDT

Nurix Therapeutics, Inc.

$NRIX4CIK: 0001549595

Subscribe to track NRIX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

NRIX CLO Sells $47K Stock for Tax Withholding

Company: Nurix Therapeutics, Inc. (NRIX) Form: 4 | Filed: 2025-10-30 Significance: Low

Insider: Ring Christine Title: Chief Legal Officer | Relationship: Officer

Transaction: • Type: Sell (Tax Withholding) • Shares: 3,644 • Price: $12.80 • Value: $46,632 • Owned After: 50,897

Key Insight: This was a non-discretionary "sell-to-cover" transaction to meet tax obligations from vesting RSUs, not a change in insider sentiment. The insider's net share position increased.

Market Context: The sale represents a negligible fraction (<0.01%) of the company's $1.21B market cap.

Comprehensive Analysis

SEC Filing Analysis: Nurix Therapeutics, Inc. (NRIX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Chief Legal Officer Christine Ring conducted a mandatory "sell-to-cover" transaction valued at ~$47k to satisfy tax obligations on newly vested Restricted Stock Units (RSUs), resulting in a net increase in her shareholdings.
  • Market Impact: Neutral. The transaction is non-discretionary and immaterial relative to the company's market cap, indicating no change in insider sentiment.

Company Information

FieldValue
CompanyNurix Therapeutics, Inc.
Ticker SymbolNRIX
CIK0001549595
IndustryPHARMACEUTICAL PREPARATIONS [2834]

Insider Information

FieldValue
NameRing Christine
CIK0001817199
Title/PositionChief Legal Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-30
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved3,644
Price Per Share$12.7967
Total Value$46,632.05
Shares Owned After50,897
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$46,632.05
% of Market Cap0.0039%
Shares Transacted3,644
% of Shares Outstanding0.0048%
Post-Transaction Ownership50,897 shares (0.067% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The ~$47k sale is insignificant for a company with a $1.21 billion market cap.
  • Ownership Concentration: The insider's post-transaction ownership of 0.067% is not a controlling stake and remains minor.
  • Dilution Impact: The associated vesting of 10,532 RSUs represents a minor dilution of ~0.014% of shares outstanding, a routine part of equity compensation.
  • Transaction Significance: The sale is a procedural requirement for tax withholding, as confirmed by footnotes, and not a discretionary trade. This gives it low significance as a market signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale was automatic and non-discretionary to cover taxes. The insider's net position increased by 6,888 shares (10,532 acquired via vesting minus 3,644 sold for taxes). This is often viewed as a neutral event as the insider is retaining the majority of the vested shares.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The trade size is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The nature of the transaction does not imply a bearish or bullish stance from the insider.

Investment Insights

Positive Market Indicators

  • The insider retained a majority (approximately 65%) of the vested shares after the mandatory tax sale, indicating a continued stake in the company's future.

Risk Factors

  • No negative risk factors are indicated by this specific transaction.

Key Takeaways

  1. The transaction was a mandatory "sell-to-cover" for tax purposes, not a discretionary sale.
  2. The sale is immaterial, representing less than 0.01% of the company's market cap and shares outstanding.
  3. The insider's net share count increased, negating any bearish interpretation of the sale.

Additional Context

Transaction Notes

  • Special Circumstances: Footnote 1 explicitly states the sale was mandated by the issuer to cover tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary trade by the reporting person.
Topics:#SECFiling#InsiderTrading#NRIX#NurixTherapeutics#Form4#SellToCover#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.